Bristol-Myers Squibb Company
Tricyclic compounds as anticancer agents

Abstract:

The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.